Literature DB >> 21671749

Distinct functional effects for dynamin 3 during megakaryocytopoiesis.

Wenjing Wang1, Diana M Gilligan, Sijie Sun, Xiaoping Wu, Jo-Anna Reems.   

Abstract

Dynamin 3 (DNM3) is a member of a family of motor proteins that participate in a number of membrane rearrangements such as cytokinesis, budding of transport vesicles, phagocytosis, and cell motility. Recently, DNM3 was implicated as having a role in megakaryocyte (MK) development. To further investigate the functional role of DNM3 during megakaryocytopoiesis, we introduced sequence-specific short hairpin RNAs (shRNAs) into developing MKs. The results showed that knockdown of DNM3 inhibited a stage of MK development that involved progenitor amplification. This was evident by significant decreases in the number of colony forming unit-megakaryocytes, the total number of nucleated cells, and the number of CD41(+) and CD61(+) MKs produced in culture. Using a styrl membrane dye to quantify the demarcation membrane system (DMS) of terminally differentiated MKs, we found that DNM3 co-localized with the DMS and that DNM3 lentiviral shRNAs precluded the formation of the DMS. Knockdown of dynamin 3 in murine MKs also caused a decrease in the number of morphologically large MKs and the overall size of large MKs was decreased relative to controls. MK protein lysates were used in overlay blots to show that both DNM3 and actin bind to nonmuscle myosin IIA (MYH9). Consistent with these observations, immunofluorescence studies of MKs and proplatelet processes showed co-localization of DNM3 with MYH9. Overall, these studies demonstrate that DNM3 not only participates in MK progenitor amplification, but is also involved in cytoplasmic enlargement and the formation of the DMS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671749      PMCID: PMC3225063          DOI: 10.1089/scd.2011.0159

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  61 in total

1.  Terminal cytokinesis events uncovered after an RNAi screen.

Authors:  Arnaud Echard; Gilles R X Hickson; Edan Foley; Patrick H O'Farrell
Journal:  Curr Biol       Date:  2004-09-21       Impact factor: 10.834

2.  An electron microscope study of the megacaryocyte of the rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat.

Authors:  O Behnke
Journal:  J Ultrastruct Res       Date:  1968-09

3.  Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response.

Authors:  J L Daniel; I R Molish; M Rigmaiden; G Stewart
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

Review 4.  Control of platelet territory development in megakaryocytes.

Authors:  J M Paulus; J Bury; J C Grosdent
Journal:  Blood Cells       Date:  1979-03-23

5.  The demarcation membrane system of the megakaryocyte: a misnomer?

Authors:  J M Radley; C J Haller
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

Review 6.  Megakaryocyte--platelet axis and the process of platelet formation and release.

Authors:  M Tavassoli
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

7.  The mechanism of platelet release.

Authors:  J M Radley; G Scurfield
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

8.  Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656.

Authors:  Brian J Lannutti; Noel Blake; Manish J Gandhi; Jo Anna Reems; Jonathan G Drachman
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

9.  MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.

Authors:  Marco Seri; Alessandro Pecci; Filomena Di Bari; Roberto Cusano; Maria Savino; Emanuele Panza; Alessandra Nigro; Patrizia Noris; Simone Gangarossa; Bianca Rocca; Paolo Gresele; Nicola Bizzaro; Paola Malatesta; Pasi A Koivisto; Ilaria Longo; Roberto Musso; Carmine Pecoraro; Achille Iolascon; Umberto Magrini; Juan Rodriguez Soriano; Alessandra Renieri; Gian Marco Ghiggeri; Roberto Ravazzolo; Carlo L Balduini; Anna Savoia
Journal:  Medicine (Baltimore)       Date:  2003-05       Impact factor: 1.889

10.  A functional genomic analysis of cell morphology using RNA interference.

Authors:  A A Kiger; B Baum; S Jones; M R Jones; A Coulson; C Echeverri; N Perrimon
Journal:  J Biol       Date:  2003-10-01
View more
  11 in total

1.  The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk.

Authors:  Youjin Wang; Jean Wactawski-Wende; Lara E Sucheston-Campbell; Leah Preus; Kathleen M Hovey; Jing Nie; Rebecca D Jackson; Samuel K Handelman; Rami Nassir; Carolyn J Crandall; Heather M Ochs-Balcom
Journal:  Am J Clin Nutr       Date:  2017-02-01       Impact factor: 7.045

2.  Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.

Authors:  Praveen K Suraneni; Seth J Corey; Michael J Hession; Rameez Ishaq; Arinola Awomolo; Shirin Hasan; Chirag Shah; Hui Liu; Amittha Wickrema; Najet Debili; John D Crispino; Elizabeth A Eklund; Yolande Chen
Journal:  Blood Adv       Date:  2018-12-11

3.  Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors.

Authors:  Danuta Jarocha; Karen K Vo; Randolph B Lyde; Vincent Hayes; Rodney M Camire; Mortimer Poncz
Journal:  Blood Adv       Date:  2018-03-27

Review 4.  The ins and outs of endocytic trafficking in platelet functions.

Authors:  Meenakshi Banerjee; Sidney W Whiteheart
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

5.  Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.

Authors:  Markus Bender; Silvia Giannini; Renata Grozovsky; Terese Jönsson; Hilary Christensen; Fred G Pluthero; Amy Ko; Ann Mullally; Walter H A Kahr; Karin M Hoffmeister; Hervé Falet
Journal:  Blood       Date:  2014-12-02       Impact factor: 22.113

6.  Dynamin-related protein-1 controls fusion pore dynamics during platelet granule exocytosis.

Authors:  Secil Koseoglu; James R Dilks; Christian G Peters; Jennifer L Fitch-Tewfik; Nathalie A Fadel; Reema Jasuja; Joseph E Italiano; Christy L Haynes; Robert Flaumenhaft
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 7.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

8.  A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site.

Authors:  Sylvia T Nürnberg; Augusto Rendon; Peter A Smethurst; Dirk S Paul; Katrin Voss; Jonathan N Thon; Heather Lloyd-Jones; Jennifer G Sambrook; Marloes R Tijssen; Joseph E Italiano; Panos Deloukas; Berthold Gottgens; Nicole Soranzo; Willem H Ouwehand
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

9.  Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci.

Authors:  Dirk S Paul; Cornelis A Albers; Augusto Rendon; Katrin Voss; Jonathan Stephens; Pim van der Harst; John C Chambers; Nicole Soranzo; Willem H Ouwehand; Panos Deloukas
Journal:  Genome Res       Date:  2013-04-09       Impact factor: 9.043

10.  Platelet granule exocytosis: a comparison with chromaffin cells.

Authors:  Jennifer L Fitch-Tewfik; Robert Flaumenhaft
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.